Scientific Reviews
Product Guides
Blogs
Topics
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!2025-02-06
17 Results for "
NOG
" in MedChemExpress (MCE) Product Catalog:
Products (17)
17 Results for "NOG" in MCE Product Catalog:
13
13
9
2
1
1 Cited Publications
Cat. No.: HY-P700286
Purity: ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: NOG; Symphalangism 1 (Proximal); Prev. SYNS1; SYNS1A; Prev. SYM1; NOGgin; Synostoses (Multiple) Syndrome 1
Species:
Mouse
Source:
HEK293
Cat. No.: HY-RS09410
Target:
Research Areas:
NOG Human Pre-designed siRNA Set A contains three designed siRNAs for NOG gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.
Cat. No.: HY-RS17067
Target:
Research Areas:
Nog Mouse Pre-designed siRNA Set A contains three designed siRNAs for Nog gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.
Cat. No.: HY-RS23511
Target:
Research Areas:
Nog Rat Pre-designed siRNA Set A contains three designed siRNAs for Nog gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.
Cat. No.: HY-175236
CAS No.: 3053768-78-5
Research Areas:
SF-9-2 is a PD-L1/PD-1 binding inhibitor (IC50 = 24.9 nM). SF-9-2 inhibits epithelial-mesenchymal transition, migration, invasion, and proliferation of SK-N-SH cells, and also induces apoptosis and cell cycle arrest. SF-9-2 blocks PD-L1-induced SK-N-SH cell growth through the MAPK signaling pathway. SF-9-2 restores GSK-3β activity and enhances PD-L1 degradation through the ubiquitin-proteasome pathway. SF-9-2 inhibits tumor growth in the SK-N-SH NOG mouse model without significant toxicity. SF-9-2 also acts as an immune checkpoint inhibitor, blocking PD-L1 to restore T cell function. SF-9-2 can be used in neuroblastoma research .
Cat. No.: HY-P991587
Target:
Research Areas:
SAR-446523 is a humanized IgG1 monoclonal antibody inhibitor targeting GPRC5D. SAR-446523 significantly induces antibody-dependent cell-mediated cytotoxicity (ADCC). SAR-446523 has potent antitumor activity with improvement of mouse survival in NK humanized NOG huIL15 transgenic mice model bearing MM cells. SAR-446523 can be used for multiple myeloma (MM) research .
Cat. No.: HY-P700143AF
Purity: ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: NOG; Symphalangism 1 (Proximal); Prev. SYNS1; SYNS1A; Prev. SYM1; NOGgin; Synostoses (Multiple) Syndrome 1
Species:
Human
Source:
E. coli
Cat. No.: HY-P70558G
Purity: ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: NOG; Symphalangism 1 (Proximal); Prev. SYNS1; SYNS1A; Prev. SYM1; NOGgin; Synostoses (Multiple) Syndrome 1
Species:
Human
Source:
HEK293
- 1
-
-
Protocols
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!A suitable model is crucial in drug screening experiments. Organs can mimic the three-dimensional functional structure of internal organs, have similar spatial organization to corresponding organs, maintain some key characteristics, and reproduce some physiological functions. They are widely used for modeling and personalized drug screening physiological functions.2025-02-06
